But this doesn't negate the drugs' potential downsides, one of which has doctors urging patients to "proceed with caution" ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

The study supports prior research that found the same thing.

Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study ...

Board-certified rheumatologist Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Ozempic and Similar Drugs Could Help Ward Off Dementia, Study Suggests According to the study researchers, however, there’s ...

Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.